Stockreport

ContraFect to Present New Clinical and Microbiological Data on CF-301 at ASM Microbe 2017

ContraFect Corporation  (CFRX) 
Last contrafect corporation earnings: 3/18 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.contrafect.com
PDF YONKERS, NY -- (Marketwired) -- 06/01/17 -- ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and [Read more]